1335192257226567680

#ASH20 has started and we’re thrilled to participate this year! Gamida Cell will be giving an oral presentation today on its ongoing Phase 1 clinical study of GDA-201, an investigational, NK cell-based cancer immunotherapy for patients with non-Hodgkin lymphoma. https://t.co/BTZnyQqOUt

Send us a message